<DOC>
	<DOCNO>NCT00740571</DOCNO>
	<brief_summary>Rationale : Often , incurable cancer patient suffer severe symptom ( neuropathic ) pain fatigue polypharmaceutic intervention consequence . Regarding neuropathic pain incurable cancer patient , pregabalin register neuropathic non-cancer pain , amitriptyline register neuropathic pain , recommend drug first choice Dutch handbooks palliative care . As consequence adaptation Dutch law ( July 2007 ) off-label medication prescription , off-label medication allow anymore unless standard protocol exists . No clinical trial patient group publish . Objective : To compare efficacy , side effect cost strategy amitriptyline drug first choice versus strategy pregabalin drug first choice . Study design : An open label , randomise non-inferiority trial Study population : Incurable cancer patient neuropathic pain Intervention : When patient decides take part study , allocate randomly one two study group . A minimisation algorithm use , balance cause neuropathic pain ( tumour relate versus treatment relate ) , type treatment ( ongoing chemo- radiotherapy versus ongoing chemo- radiotherapy ) institution . Each drug prescribe step procedure . Patients follow 8 week . Main study parameters/endpoints : Neuropathic pain , measure mean VAS McGill questionnaire , strategy success , cost per strategy , side effect , quality life concomitant analgesic drug . Nature extent burden risk associate participation , benefit group relatedness : There hardly risk patient . The drug arm already usual care target population . If small effect , drug arm add , strategy also already usual care . All medication , except Tricyclic Antidepressants Drugs ( TADs ) Anti Epileptic Drugs ( AEDs ) , well radiotherapy chemotherapy allow . The patient visit hospital 2 time study period . The patient fill pain diary daily ( 5 min ) , cost diary EQ-5D every week ( 10 min ) , related questionnaire HADS , McGill EORTC-QLQ-C30 monthly ( 20 min ) .</brief_summary>
	<brief_title>Amitriptyline Pregabalin Treat Neuropathic Pain Incurable Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<criteria>Age 18+ Incurable cancer Life expectancy three month longer NRS ≥ 4 Neuropathic pain Adequate renal function cockroft ≥ 60 ml/min Signed informed consent Expected adequacy follow Previous use TAD AED neuropathic pain within 30 day prior screen Unstable regime analgetica 1 week prior screen Use cannabis Radiotherapy aim source neuropathic pain 2 week screen Chemotherapy know neurotoxic effect ( taxanes , thalidomide , vinca alkaloid , cytarabine , fluoropyrimidines , oxaliplatin ) 2 week screen Unstable regime corticosteroid 1 week prior screen Pregnancy Any condition prevent intake absorption oral drug Participation study involve investigational product within 30 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>neuralgia</keyword>
	<keyword>off-label</keyword>
	<keyword>cancer</keyword>
</DOC>